Skip to main content
Top
Published in: BMC Infectious Diseases 1/2005

Open Access 01-12-2005 | Research article

Bacterial isolates from blood cultures of children with suspected septicaemia in Calabar, Nigeria

Authors: Martin M Meremikwu, Chukwuemeka E Nwachukwu, Anne E Asuquo, Joseph U Okebe, Simon J Utsalo

Published in: BMC Infectious Diseases | Issue 1/2005

Login to get access

Abstract

Background

Septicaemia is a common cause of morbidity and mortality among children in the developing world. This pattern has changed little in the past decade. Physical signs and symptoms, though useful in identifying possible cases have limited specificity. Definitive diagnosis is by bacteriologic culture of blood samples to identify organisms and establish antibiotic susceptibility. These results are usually not available promptly. Therefore a knowledge of epidemiologic and antimicribial susceptibility pattern of common pathogens is useful for prompt treatment of patients. This report highlights the pattern of bacterial isolates in our environment from a retrospective study of our patients' records.

Methods

One thousand, two hundred and one blood samples were analysed from children aged 0–15 years, admitted into the children's wards of the University of Calabar Teaching Hospital, Calabar, Nigeria with features suggesting septicaemia. Samples were collected under aseptic conditions and cultured for aerobic and anaerobic organisms. Isolates were identified using bacteriologic and biochemical methods and antibiotic sensitivity determined by agar diffusion method using standard antibiotic discs.

Results

Bacteria was isolated in 552 (48.9%) of samples with highest rates among newborns (271 : 50.8). The most frequent isolates were Staphylococcal aureus (48.7%) and Coliforms (23.4%). Results showed high susceptibilities to the Cephalosporins (Ceftriazone- 100%:83.2%, Cefuroxime-100%:76.5%) and Macrolides (Azithromycin-100%:92.9%) for S. aureus and coliforms respectively. This study underscores the importance of septicaemia as a common cause of febrile illness in children and provides information on common prevalent aetiologic agents and drug susceptibilities of the commonest pathogens.

Conclusion

Staphylococcus aureus and coliforms were the leading causes of septicaemia in children in this locality, and the third generation cephalosporins and azithromycin were shown to be effective against these pathogens.
Literature
1.
go back to reference Asindi AA, Ekanem AD: Neonatal septicaemia in Calabar Nigeria. East African Medical Journal. 1988, 65 (5): 335-41.PubMed Asindi AA, Ekanem AD: Neonatal septicaemia in Calabar Nigeria. East African Medical Journal. 1988, 65 (5): 335-41.PubMed
2.
go back to reference Asindi AA, Ibia EO, Udo JJ: Mortality pattern among Nigerian children in the 1980s. J Trop Med Hyg. 1991, 94: 152-155.PubMed Asindi AA, Ibia EO, Udo JJ: Mortality pattern among Nigerian children in the 1980s. J Trop Med Hyg. 1991, 94: 152-155.PubMed
3.
go back to reference Omene JA: Neonatal septicaemia in Benin City (Nigeria). A review of 74 cases. Tropical Geographical Medicine. 1979, 31: 35-39.PubMed Omene JA: Neonatal septicaemia in Benin City (Nigeria). A review of 74 cases. Tropical Geographical Medicine. 1979, 31: 35-39.PubMed
4.
go back to reference Adejuyigbe EA, Adeodu OO, Ako-Nai KA, Taiwo O, Owa JA: Septicaemia in high risk neonates at a teaching hospital in Ile-Ife, Nigeria. East Afr Med J. 2001, 78 (10): 540-3.CrossRefPubMed Adejuyigbe EA, Adeodu OO, Ako-Nai KA, Taiwo O, Owa JA: Septicaemia in high risk neonates at a teaching hospital in Ile-Ife, Nigeria. East Afr Med J. 2001, 78 (10): 540-3.CrossRefPubMed
5.
go back to reference Hague RA, Eastman EJ, Lee RE, Cant AJ: Resolution of hepatic abcess after interferon gamma in chronic granulomatous disease. Arch Dis child. 1993, 69 (4): 443-5.CrossRefPubMedPubMedCentral Hague RA, Eastman EJ, Lee RE, Cant AJ: Resolution of hepatic abcess after interferon gamma in chronic granulomatous disease. Arch Dis child. 1993, 69 (4): 443-5.CrossRefPubMedPubMedCentral
6.
go back to reference Weber MW, Carlin JB, Gatchalian S, Lehmann D, Muhe L, Mulholland EK, WHO Young Infants Study Group: Predictors of neonatal sepsis in developing countries. Pediatr Infect Dis J. 2003, 22 (8): 711-7.CrossRefPubMed Weber MW, Carlin JB, Gatchalian S, Lehmann D, Muhe L, Mulholland EK, WHO Young Infants Study Group: Predictors of neonatal sepsis in developing countries. Pediatr Infect Dis J. 2003, 22 (8): 711-7.CrossRefPubMed
7.
go back to reference Singh SA, Dutta S, Narang A: Predictive clinical scores for diagnosis of late onset neonatal septicemia. J Trop Pediatr. 2003, 49 (4): 235-9. 10.1093/tropej/49.4.235.CrossRefPubMed Singh SA, Dutta S, Narang A: Predictive clinical scores for diagnosis of late onset neonatal septicemia. J Trop Pediatr. 2003, 49 (4): 235-9. 10.1093/tropej/49.4.235.CrossRefPubMed
8.
go back to reference Finegold SM, Markin WJ, Scott EJ: Bailey & Scott's Diagnostic Microbiology. 1978, St. Louis: The CV Mosby Company, 5 Finegold SM, Markin WJ, Scott EJ: Bailey & Scott's Diagnostic Microbiology. 1978, St. Louis: The CV Mosby Company, 5
9.
go back to reference Oxoid Ltd, Wade, Road Basingstoke Hampshire, RG24 8PW England. Oxoid Ltd, Wade, Road Basingstoke Hampshire, RG24 8PW England.
10.
go back to reference Antia-Obong OE, Utsalo SJ, Udo JJ, Udo KT: Neonatal septicaemia in Calabar, Nigeria. Cent Afr J Med. 1992, 38 (4): 161-5.PubMed Antia-Obong OE, Utsalo SJ, Udo JJ, Udo KT: Neonatal septicaemia in Calabar, Nigeria. Cent Afr J Med. 1992, 38 (4): 161-5.PubMed
11.
go back to reference Mokuolu AO, Jiya N, Adesiyun OO: Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern. Afr J Med Med Sci. 2002, 31 (2): 127-30.PubMed Mokuolu AO, Jiya N, Adesiyun OO: Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern. Afr J Med Med Sci. 2002, 31 (2): 127-30.PubMed
12.
go back to reference Ako-Nai AK, Adejuyigbe EA, Ajayi FM, Onipede AO: The bacteriology of neonatal septicaemia in Ile-Ife, Nigeria. J Trop Pediatr. 1999, 45 (3): 146-51. 10.1093/tropej/45.3.146.CrossRefPubMed Ako-Nai AK, Adejuyigbe EA, Ajayi FM, Onipede AO: The bacteriology of neonatal septicaemia in Ile-Ife, Nigeria. J Trop Pediatr. 1999, 45 (3): 146-51. 10.1093/tropej/45.3.146.CrossRefPubMed
13.
go back to reference Aurangzeb B, Hameed A: Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns. J Coll Physicians Surg Pak. 2003, 13 (11): 629-32.PubMed Aurangzeb B, Hameed A: Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns. J Coll Physicians Surg Pak. 2003, 13 (11): 629-32.PubMed
14.
go back to reference Antia-Obong OE, Utsalo SJ: Bacterial agents in neonatal septicaemia in Calabar, Nigeria: review of 100 cases. Trop Doct. 1991, 21 (4): 169-70.PubMed Antia-Obong OE, Utsalo SJ: Bacterial agents in neonatal septicaemia in Calabar, Nigeria: review of 100 cases. Trop Doct. 1991, 21 (4): 169-70.PubMed
Metadata
Title
Bacterial isolates from blood cultures of children with suspected septicaemia in Calabar, Nigeria
Authors
Martin M Meremikwu
Chukwuemeka E Nwachukwu
Anne E Asuquo
Joseph U Okebe
Simon J Utsalo
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2005
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-5-110

Other articles of this Issue 1/2005

BMC Infectious Diseases 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine